Navigation Links
Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
Date:11/6/2008

tar.com.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and conjugate chemistry technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules.

For more information on Nektar Therapeutics, please visit http://www.nektar.com.

This press release contains forward-looking statements that reflect the company's current views regarding the status of the company's turnaround, the potential, progress, and clinical plans for the company's proprietary and partnered product pipeline, the value and potential of the company's technology platforms, and the company's financial strength. These forward- looking statements involve risks and uncertainties, including but not limited to: (i) the company's proprietary product candidates and those of its partners are in various stages of clinical development and the risk of failure is high and can occur at any stage prior to regulatory approval; (ii) the timing or success of the commencement or end of clinical trials and commercial launch of partnered products may be delayed or unsuccessful due to slower than anticipated patient enrollment, drug manufacturing challenges, changing standards of care, clinical trial design, clinical outcomes, or delay or failure in obtaining regulatory approval in one or more important markets; (iii) clinical trials are long, expensive and uncertain processes and the risk of failure of any product that is in clinical development and prior to regulatory approval remains high and can occur at any stage due to efficacy, safety or other factors; , and (iv) th
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Announces Second Quarter 2008 Results
3. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
4. Nektar Therapeutics Announces First Quarter 2008 Results
5. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
6. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
7. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
10. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
11. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...gement Health Solutions, Inc. (MHS) has signed a t...ter, the largest hospital in southwest Colorado, t...cility in Durango, Colorado. MHS will perform this...ss. www.MHSInc.com , Fa...
... the Easter holiday fast approaching, tons of choc...is asked what the difference is between white, dar...u. , (PRWEB) March 31, 20...ts for children, and the child in all of us. Some...
...ng the list for the 13th time, more than any hospi...n, IL (Vocus) April 1, 2009 -- NorthShore Univers...e nation,s 100 Top Hospitals® by Thomson Reute...named a Top 100 Hospital thirteen times, more time...
...t of Original Web Episodes Live Now at yogajournal...s demand creative solutions. In a surprise move th...Journal Magazine announces it has hired Ogden, als...ble his way though yoga classes, offending his fem...
...MONT, IL A popular cable reality television show, ...es of short stature individuals. This series brin..., into the spotlight. According to a literature r...m is an extremely complex process. Orthopaedic su...
...IN, Mo., April 1 Local and national public health... in calling on Governor Jay Nixon for a thorough i...cidence in Joplin of birth defects and chronic dis...all for government action accompanies release of a...
Other Medicine News:Health News:Mercy Regional Medical Center Selects Management Health Solutions, Inc. for Inventory Services 2Health News:Poison Dressed as an Easter Bunny 2Health News:NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters 2Health News:NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters 3Health News:In Five-Part Video Series, Yoga Journal Hires 'The Inappropriate Yoga Guy' as 'Editor' 2Health News:Dealing with dwarfism 2Health News:Dealing with dwarfism 3Health News:Joplin Citizens and Health Organizations Call on Missouri Gov. Nixon for Study, Action on High Incidence of Birth Defects and Chronic Diseases in Community 2
(Date:12/4/2009)WASHINGTON, Dec. 4 A simple, inexpensive computer tool that measures volume changes in the size of suspicious nodules in the lungs picked up by a CT scanner can rule out non-cancerous ones with almos
(Date:12/4/2009)MARLTON, N.J., Dec. 4 Thermographic Diagnostic Imaging (TDI), part of a Health & Wellness Center in Marlton, New Jersey continues to provide superior quality infrared imaging of the breast, neuro
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
Breaking Medicine Technology:European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 1Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 2Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 47581 3Seasonal Flu Lingers 47579 1Seasonal Flu Lingers 47579 2Garden of Life Partners with WomenHeart to Help Combat Womens Heart Disease 47578 1Garden of Life Partners with WomenHeart to Help Combat Womens Heart Disease 47578 2
Black Multi-Pinhole Occluder
Long Handle Occluder - Black
60mm Lens Blank
Translucent White-Long
Medicine Products: